General Information
Version
8.4
Revision date
2022-10-13
Product name
C5 Lenalidomide-PEG1-NH2 hydrochloride
REACH No
is
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d, H373
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H361d Suspected of damaging the unborn child. H373 May cause damage to organs (Blood) through prolonged or repeated exposure. Reduced Labeling (<= 125 ml) H361d Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
